1. Li, B., et al., Consumption of sugar sweetened beverages, artificially sweetened beverages and fruit juices and risk of type 2 diabetes, hypertension, cardiovascular disease, and mortality: A meta-analysis. Front Nutr, 2023. 10: p. 1019534.
  2. Meng, Y., et al., Sugar- and Artificially Sweetened Beverages Consumption Linked to Type 2 Diabetes, Cardiovascular Diseases, and All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrients, 2021. 13(8).
  3. Santos, L.P., et al., Sugar sweetened beverages intake and risk of obesity and cardiometabolic diseases in longitudinal studies: A systematic review and meta-analysis with 1.5 million individuals. Clin Nutr ESPEN, 2022. 51: p. 128-142.
  4. Lee, J.J., et al., Relation of change or substitution of low-and no-calorie sweetened beverages with cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies. Diabetes Care, 2022. 45(8): p. 1917-1930.
  5. Greyling, A., et al., Acute glycemic and insulinemic effects of low-energy sweeteners: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr, 2020. 112(4): p. 1002-1014.
  6. McGlynn, N.D., et al., Association of low-and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and meta-analysis. JAMA network open, 2022. 5(3): p. e222092-e222092.
  7. Rios-Leyvraz, M., J. Montez, and W.H. Organization, Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. 2022.
  8. Zafar, M.I., M. Frese, and K.E. Mills, Chronic Fructose Substitution for Glucose or Sucrose in Food or Beverages and Metabolic Outcomes: An Updated Systematic Review and Meta-Analysis. Front Nutr, 2021. 8: p. 647600.
  9. Dos Santos Lima, É., et al., Metabolic and Appetite Effects of Fructose and Glucose in Subjects with Type 1 Diabetes: A Randomized Crossover Clinical Trial. Curr Diabetes Rev, 2021. 17(6): p. e113020188536.
  10. Li, X., et al., Fructose consumption from different food sources and cardiometabolic biomarkers: cross-sectional associations in US men and women. Am J Clin Nutr, 2023. 117(3): p. 490-498.
  11. Buziau, A.M., et al., Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study. Diabetes Care, 2022. 45(5): p. 1116-1123.
  12. Kanehara, R., et al., Association between sugar and starch intakes and type 2 diabetes risk in middle-aged adults in a prospective cohort study. Eur J Clin Nutr, 2022. 76(5): p. 746-755.
  13. Jalilvand, A., et al., Effects of low fructose diet on glycemic control, lipid profile and systemic inflammation in patients with type 2 diabetes: A single-blind randomized controlled trial. Diabetes Metab Syndr, 2020. 14(5): p. 849-855.
  14. Schwingshackl, L., et al., Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. European journal of epidemiology, 2017. 32: p. 363-375.
  15. Halvorsen, R.E., et al., Fruit and vegetable consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective studies. BMJ Nutr Prev Health, 2021. 4(2): p. 519-531.
  16. Scheffers, F.R., et al., Substitution of pure fruit juice for fruit and sugar-sweetened beverages and cardiometabolic risk in European Prospective Investigation into Cancer and Nutrition (EPIC)-NL: a prospective cohort study. Public Health Nutr, 2022. 25(6): p. 1504-1514.
  17. Yong, H.Y., et al., Beverage Intake and the Risk of Gestational Diabetes Mellitus: The SECOST. Nutrients, 2021. 13(7).
  18. Li, H., et al., Mid-pregnancy consumption of fruit, vegetable and fruit juice and the risk of gestational diabetes mellitus: A correlation study. Clin Nutr ESPEN, 2021. 46: p. 505-509.
  19. Bondonno, N.P., et al., Associations Between Fruit Intake and Risk of Diabetes in the AusDiab Cohort. J Clin Endocrinol Metab, 2021. 106(10): p. e4097-e4108.
  20. Moon, J.Y., et al., Association of Sugar-Sweetened Beverage Consumption with Prediabetes and Glucose Metabolism Markers in Hispanic/Latino Adults in the United States: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Nutr, 2022. 152(1): p. 235-245.
  21. Te Morenga, L., S.R. Mallard, and F.B. Ormerod, No Effect of Added Sugars in Soft Drink Compared With Sugars in Fruit on Cardiometabolic Risk Factors: Results From a 4-Week, Randomized Controlled Trial. Front Nutr, 2021. 8: p. 636275.
  22. Kanbay, M., et al., The Speed of Ingestion of a Sugary Beverage Has an Effect on the Acute Metabolic Response to Fructose. Nutrients, 2021. 13(6).
  23. Fumanelli, J., et al., Treatment of hypoglycemia during prolonged physical activity in adolescents with type 1 diabetes mellitus. Acta Biomed, 2020. 91(4): p. e2020103.
  24. Erbas, I.M., et al., Comparison of the effectiveness of simple carbohydrates on hypoglycemic episodes in children and adolescents with type 1 diabetes mellitus: A randomized study in a diabetes camp. Pediatr Diabetes, 2020. 21(7): p. 1249-1255.
  25. Murillo, S., et al., Management of Hypoglycemia in Adults with Type 1 Diabetes in Real-Life Condition. Ann Nutr Metab, 2020. 76(4): p. 277-284.
  26. Churuangsuk, C., et al., Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia, 2022. 65(1): p. 14-36.
  27. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia, 2023. 66(6): p. 965-985.
  28. Zaki, H.A., et al., Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis. Cureus, 2022. 14(10): p. e30879.
  29. Borgundvaag, E., J. Mak, and C.K. Kramer, Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies. J Clin Endocrinol Metab, 2021. 106(3): p. 902-911.
  30. Wang, X., et al., Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract, 2021. 179: p. 109003.
  31. Benson, G. and J. Hayes, An update on the Mediterranean, vegetarian, and DASH eating patterns in people with type 2 diabetes. Diabetes Spectrum, 2020. 33(2): p. 125-132.
  32. Marx, N., et al., 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). European Heart Journal, 2023: p. ehad192.
  33. Alvirdizadeh, S., et al., A prospective study on total protein, plant protein and animal protein in relation to the risk of incident chronic kidney disease. BMC nephrology, 2020. 21(1): p. 1-7.
  34. Jardine, M.A., et al., Perspective: plant-based eating pattern for type 2 diabetes prevention and treatment: efficacy, mechanisms, and practical considerations. Advances in Nutrition, 2021. 12(6): p. 2045-2055.
  35. Chen, X., et al., Associations of ultra-processed food consumption with cardiovascular disease and all-cause mortality: UK Biobank. European Journal of Public Health, 2022. 32(5): p. 779-785.
  36. Moradi, S., et al., Ultra-processed food consumption and adult diabetes risk: A systematic review and dose-response meta-analysis. Nutrients, 2021. 13(12): p. 4410.
  37. Isaksen, I.M. and S.N. Dankel, Ultra-processed food consumption and cancer risk: a systematic review and meta-analysis. Clinical Nutrition, 2023.
  38. Duan, M.-J., et al., Ultra-processed food and incident type 2 diabetes: studying the underlying consumption patterns to unravel the health effects of this heterogeneous food category in the prospective Lifelines cohort. BMC medicine, 2022. 20(1): p. 1-11.
  39. Vaisman, N., et al., Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients. Clin Nutr, 2009. 28(5): p. 549-55.
  40. Alish, C.J., et al., A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes technology & therapeutics, 2010. 12(6): p. 419-425.
  41. Mesejo, A., et al., Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study. Crit Care, 2015. 19: p. 390.
  42. Craig, L.D., et al., Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition, 1998. 14(6): p. 529-34.
  43. Mesejo, A., et al., Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr, 2003. 22(3): p. 295-305.
  44. Pohl, M., et al., Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr, 2005. 59(11): p. 1221-32.
  45. de Luis Román, D., et al., A prospective, observational study of the use of a high-calorie, high-protein tube feeding formula with slow-release carbohydrates and monounsaturated fatty acids in a malnourished population with diabetes. Clinical Nutrition Open Science, 2022. 44: p. 107-117.
  46. Pohl, M., et al., Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN J Parenter Enteral Nutr, 2009. 33(1): p. 37-49.
  47. Doola, R., et al., The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: A blinded randomised feasibility trial. Clin Nutr ESPEN, 2019. 31: p. 80-87.
  48. Ballesteros Pomar, M.D., et al., A real-life study of the medium to long-term effectiveness of a hypercaloric, hyperproteic enteral nutrition formula specifically for patients with diabetes on biochemical parameters of metabolic control and nutritional status. Endocrinol Diabetes Nutr (Engl Ed), 2022. 69(5): p. 331-337.
  49. Mori, Y., et al., The effect of a low-carbohydrate/high-monounsaturated fatty acid liquid diet and an isoleucine-containing liquid diet on 24-h glycemic variability in diabetes patients on tube feeding: a comparison by continuous glucose monitoring. Diabetes Technol Ther, 2012. 14(7): p. 619-23.
  50. León-Sanz, M., et al., Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN J Parenter Enteral Nutr, 2005. 29(1): p. 21-9.
  51. van Steen, S.C., et al., Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial. JPEN J Parenter Enteral Nutr, 2018. 42(6): p. 1035-1045.
  52. Han, Y.-Y., et al., The clinical and economic impact of the use of diabetes-specific enteral formula on ICU patients with type 2 diabetes. Clinical Nutrition, 2017. 36(6): p. 1567-1572.
  53. Mori, Y., et al., Effects of low-carbohydrate/high-monounsaturated fatty acid liquid diets on diurnal glucose variability and insulin dose in type 2 diabetes patients on tube feeding who require insulin therapy. Diabetes Technol Ther, 2013. 15(9): p. 762-7.
  54. de Luis, D.A., et al., A randomized clinical trial with two enteral diabetes-specific supplements in patients with diabetes mellitus type 2: metabolic effects. Eur Rev Med Pharmacol Sci, 2008. 12(4): p. 261-6.
  55. Sanz-Paris, A., et al., Health-Care Costs, Glycemic Control and Nutritional Status in Malnourished Older Diabetics Treated with a Hypercaloric Diabetes-Specific Enteral Nutritional Formula. Nutrients, 2016. 8(3): p. 153.
  56. Magnoni, D., et al., Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients. Diabetes Res Clin Pract, 2008. 80(1): p. 75-82.
  57. Laksir, H., et al., Glycaemic response after intake of a high energy, high protein, diabetes-specific formula in older malnourished or at risk of malnutrition type 2 diabetes patients. Clin Nutr, 2018. 37(6 Pt A): p. 2084-2090.
  58. del Carmen Crespillo, M., et al., Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr, 2003. 22(5): p. 483-7.
  59. Peters, A.L., M.B. Davidson, and R.M. Isaac, Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med, 1989. 87(2): p. 178-82.
  60. Ojo, O. and J. Brooke, Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients, 2014. 6(11): p. 5142-5152.
  61. Davidson, P., C.A. Kwiatkowski, and M. Wien, Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient. Nutr Clin Pract, 2015. 30(5): p. 652-9.
  62. Ojo, O., et al., The effect of diabetes-specific enteral nutrition formula on cardiometabolic parameters in patients with type 2 diabetes: a systematic review and meta–analysis of randomised controlled trials. Nutrients, 2019. 11(8): p. 1905.
  63. Stamati, A., et al., Efficacy and safety of carbohydrate restriction in patients with type 1 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab, 2023.
  64. Dyńka, D., et al., Effect of the Ketogenic Diet on the Prophylaxis and Treatment of Diabetes Mellitus: A Review of the Meta-Analyses and Clinical Trials. Nutrients, 2023. 15(3).
  65. Gezondheidsraad, Richtlijnen goede voeding voor mensen met diabetes type 2. 2021.
  66. Reynolds, A., Evidence-based European recommendations for the dietary management of diabetes. Diabetologia, 2023: p. 1-21.
  67. Merino, J., Precision nutrition in diabetes: when population-based dietary advice gets personal. Diabetologia, 2022. 65(11): p. 1839-1848.
  68. Omura, Y., et al., Effects of individualized dietary advice compared with conventional dietary advice for adults with type 2 diabetes: A randomized controlled trial. Nutr Metab Cardiovasc Dis, 2022. 32(4): p. 1035-1044.
  69. Ahlqvist, E., et al., Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. The lancet Diabetes & endocrinology, 2018. 6(5): p. 361-369.
  70. Trouwborst, I., et al., Ectopic fat accumulation in distinct insulin resistant phenotypes; targets for personalized nutritional interventions. Frontiers in nutrition, 2018. 5: p. 77.
  71. Zhao, P.-P., et al., Relationship between alcohol use, blood pressure and hypertension: an association study and a Mendelian randomisation study. J Epidemiol Community Health, 2019. 73(9): p. 796-801.
  72. Roerecke, M., et al., The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. The Lancet Public Health, 2017. 2(2): p. e108-e120.
  73. Csengeri, D., N.-A. Sprünker, and R.B. Schnabel, Alcohol and atrial fibrillation: dose matters, not so much the type. European Heart Journal, 2021. 42(25): p. 2507-2508.
  74. Rumgay, H., et al., Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. The Lancet Oncology, 2021. 22(8): p. 1071-1080.
  75. Rehm, J., et al., Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The lancet, 2009. 373(9682): p. 2223-2233.
  76. Paradis, C., et al., Canada’s Guidance on Alcohol and Health: Final Report. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction, 2023.
  77. Vetrani, C., et al., Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system. Diabetologia, 2022. 65: p. 79-87.
  78. Poggiogalle, E., H. Jamshed, and C.M. Peterson, Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism, 2018. 84: p. 11-27.
  79. Halvorsen, R. E., Elvestad, M., Molin, M., & Aune, D. (2021). Fruit and vegetable consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of prospective studies. BMJ nutrition, prevention & health, 4(2), 519.